Streetbeat News

Earnings

BNGO

Bionano Genomics (NASDAQ:BNGO) is scheduled to release its quarterly earnings report on March 5, 2024, with analysts expecting an EPS of $-0.87. The company's past earnings performance shows a trend of not meeting EPS estimates, leading to varying stock price reactions. Shares are currently trading at $1.25, reflecting a 90.84% decline over the last year. Investors are looking for positive guidance for the next quarter.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 6:03 pm

ISPO

Inspirato (NASDAQ:ISPO) is scheduled to release its quarterly earnings report on March 5, 2024, with analysts expecting an EPS of $-3.66. The company's past earnings performance shows a trend of not meeting EPS estimates, leading to significant share price drops. Shares are currently trading at $5.25, down 95.07% over the last year, indicating a bearish outlook from long-term shareholders.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 6:03 pm

NUWE

Nuwellis (NASDAQ:NUWE) is scheduled to release its quarterly earnings report on 2024-03-05, with analysts expecting an EPS of $-1.39. The company's past earnings performance shows a mixed impact on its stock price, with the last quarter's beat leading to a 4.69% drop. Shares are currently trading at $0.5902, down 90.37% over the last year, indicating a bearish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 6:03 pm

RIGL

Rigel Pharmaceuticals (NASDAQ:RIGL) is scheduled to release its quarterly earnings report on Tuesday, 2024-03-05, with analysts estimating an EPS of $-0.03. The company's past earnings performance shows a pattern of beating EPS estimates, leading to varying stock price changes. Shares were trading at $1.55 as of March 01, with a 1.02% increase over the last 52 weeks. Investors are looking for not only an earnings beat but also positive guidance for the next quarter.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 6:03 pm

PSTV

Plus Therapeutics (NASDAQ:PSTV) is scheduled to release its quarterly earnings report on March 5, 2024, with an expected EPS of $-1.07. The company's past earnings performance shows a mix of beats and misses, with the share price reacting accordingly. Shares are currently trading at $1.99, down 56.13% over the last year. Investors are looking for positive guidance for the next quarter.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 6:03 pm

SCKT

Socket Mobile (NASDAQ:SCKT) is scheduled to release its quarterly earnings report on March 5, 2024, with analysts expecting an EPS of $-0.06. The company's past earnings performance shows a mixed record of beating and missing EPS estimates, with share price reactions varying accordingly. Over the last year, SCKT shares have declined by 50.93%, reflecting investor concerns. Investors will be closely watching for not only the earnings results but also the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 6:03 pm

OFS

OFS Capital (NASDAQ:OFS) is scheduled to release its quarterly earnings report on March 5, 2024, with analysts predicting an EPS of $0.39. The company's past performance shows a trend of beating EPS estimates, which has occasionally led to positive stock price movements. Shares of OFS Capital have increased by 13.26% over the last 52 weeks, indicating a generally positive outlook from long-term shareholders. Investors will be particularly attentive to the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 6:03 pm

NYXH

Nyxoah (NASDAQ:NYXH) is scheduled to release its quarterly earnings report on March 5, 2024, with analysts expecting an EPS of $-0.40. The company's past performance shows a mixed reaction to earnings reports, with the last quarter beating estimates but followed by a 15.1% drop in share price. Shares have risen 187.02% over the last 52 weeks, indicating long-term shareholder optimism.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 6:02 pm

MASS

908 Devices (NASDAQ:MASS) is scheduled to release its quarterly earnings report on March 5, 2024, with an expected EPS of $-0.26. Investors are hopeful for a beat on this estimate and positive guidance for the next quarter. Historically, the company's share price has reacted variably to past earnings reports, with a notable 8.69% drop after last quarter's beat. Over the last year, MASS shares have declined by 21.13%, indicating a bearish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 6:02 pm

STIM

Neuronetics (NASDAQ:STIM) is scheduled to release its quarterly earnings report on March 5, 2024, with an expected EPS of $-0.26. Despite missing the EPS estimate last quarter by $0.02, the stock price increased by 4.29% the following day. Historical performance shows mixed results post-earnings, with shares currently down 30.17% over the last 52 weeks. Investors are looking for positive guidance for the next quarter.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 6:02 pm